[1]Liu L, Chen J, Wang L, et al. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database [J]. Front Endocrinol, 2022, 13: 1043789.

